Combination of bleomycin, etoposide and cisplatin (BEP) versus etoposide and cisplatin (EP) in patients with good risk nonseminomatous germ cell tumors (NSGCT)

被引：0
|
作者：
Tryakin, A. [1 ]
Fedyanin, M. [1 ]
Bulanov, A. [1 ]
Titov, D. [1 ]
Mitin, A. [2 ]
Sergeev, J. [3 ]
Figurin, K. [2 ]
Fainstein, I. [3 ]
Matveev, V. [2 ]
Zakharova, T. [4 ]
Kostjakova, L. [5 ]
Garin, A. [1 ]
Tjulandin, S. [1 ]
机构：
[1] NN Blokhin Russian Canc Res Ctr, Clin Pharmacol & Chemotherapy, Moscow, Russia
[2] NN Blokhin Russian Canc Res Ctr, Urol, Moscow, Russia
[3] NN Blokhin Russian Canc Res Ctr, Radiosurg, Moscow, Russia
[4] NN Blokhin Russian Canc Res Ctr, Pathomorphol, Moscow, Russia
[5] NN Blokhin Russian Canc Res Ctr, Radiol, Moscow, Russia
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31428-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2610
引用
收藏
页码：S515 / S515
页数：1
相关论文
共 50 条
  • [31] Drug dose delivery and treatment outcome relationship in standard bleomycin, etoposide and cisplatin combination chemotherapy in nonseminomatous germ cell tumor patients
    Gutierrez-Delgado, F
    Titov, DA
    Tjulandin, SA
    Garin, AM
    NEOPLASMA, 1999, 46 (03) : 190 - 195
  • [32] Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors
    Pautier, P.
    Gutierrez-Bonnaire, M.
    Rey, A.
    Sillet-Bach, I.
    Chevreau, C.
    Kerbrat, P.
    Morice, P.
    Duvillard, P.
    Lhomme, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (03) : 446 - 452
  • [33] TREATMENT OF DISSEMINATED GERM-CELL TUMORS WITH CISPLATIN, BLEOMYCIN, AND EITHER VINBLASTINE OR ETOPOSIDE
    WILLIAMS, SD
    BIRCH, R
    EINHORN, LH
    IRWIN, L
    GRECO, FA
    LOEHRER, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (23): : 1435 - 1440
  • [34] Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin
    Lauritsen, Jakob
    Kier, Maria Gry Gundgaard
    Bandak, Mikkel
    Mortensen, Mette Sakso
    Thomsen, Frederik Birkebaek
    Mortensen, Jann
    Daugaard, Gedske
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1492 - +
  • [35] HIGH FAILURE RATE OF CARBOPLATIN ETOPOSIDE COMBINATION IN GOOD RISK NONSEMINOMATOUS GERM-CELL TUMORS
    KATTAN, J
    MAHJOUBI, M
    DROZ, JP
    KRAMAR, A
    CULINE, S
    BOUTANLAROZE, A
    CHAZARD, M
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (11) : 1504 - 1509
  • [36] ETOPOSIDE, CISPLATIN, BLEOMYCIN, AND CYCLOPHOSPHAMIDE (ECBC) AS 1ST-LINE CHEMOTHERAPY FOR POOR-RISK NONSEMINOMATOUS GERM-CELL TUMORS
    GERL, A
    CLEMM, C
    HENTRICH, M
    HARTENSTEIN, R
    WILMANNS, W
    ACTA ONCOLOGICA, 1993, 32 (05) : 541 - 546
  • [37] COMBINATION CHEMOTHERAPY WITH VINBLASTINE, BLEOMYCIN, CISPLATIN, AND ETOPOSIDE (VBPE) IN CHILDREN WITH PRIMARY INTRACRANIAL GERM-CELL TUMORS
    CHANG, TK
    WONG, TT
    HWANG, B
    MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (06): : 368 - 372
  • [38] ETOPOSIDE PLUS CARBOPLATIN OR CISPLATIN IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS - A RANDOMIZED COMPARISON
    BOSL, GJ
    BAJORIN, DF
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 61 - 64
  • [39] Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
    Einhorn, Lawrence H.
    Adra, Nabil
    Hanna, Nasser
    Nichols, Craig
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26)
  • [40] EFFECTIVENESS OF CARBOPLATIN, ETOPOSIDE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN GOOD-PROGNOSIS METASTATIC TESTICULAR NONSEMINOMATOUS GERM-CELL TUMORS
    HORWICH, A
    DEARNALEY, DP
    NICHOLLS, J
    JAY, G
    MASON, M
    HARLAND, S
    PECKHAM, MJ
    HENDRY, WF
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) : 62 - 69
12345